<code id='A4CE9E2911'></code><style id='A4CE9E2911'></style>
    • <acronym id='A4CE9E2911'></acronym>
      <center id='A4CE9E2911'><center id='A4CE9E2911'><tfoot id='A4CE9E2911'></tfoot></center><abbr id='A4CE9E2911'><dir id='A4CE9E2911'><tfoot id='A4CE9E2911'></tfoot><noframes id='A4CE9E2911'>

    • <optgroup id='A4CE9E2911'><strike id='A4CE9E2911'><sup id='A4CE9E2911'></sup></strike><code id='A4CE9E2911'></code></optgroup>
        1. <b id='A4CE9E2911'><label id='A4CE9E2911'><select id='A4CE9E2911'><dt id='A4CE9E2911'><span id='A4CE9E2911'></span></dt></select></label></b><u id='A4CE9E2911'></u>
          <i id='A4CE9E2911'><strike id='A4CE9E2911'><tt id='A4CE9E2911'><pre id='A4CE9E2911'></pre></tt></strike></i>

          leisure time

          leisure time

          author:comprehensive    Page View:296
          Richard Burr
          North Carolina Senator Richard Burr received strong support from the biotech sector. Gerry Broome/AP

          WASHINGTON — A veteran senator and champion of the biotech sector beat back an unusually strong challenge Tuesday night — thanks in large part to loyal support from the industry.

          North Carolina Senator Richard Burr, a Republican who has long protected the bioscience companies that drive his state’s economy, overcame a surprisingly robust challenge from Democratic candidate Deborah K. Ross.

          advertisement

          Burr, now finishing his second term in the Senate, serves on committees with oversight of both the Food and Drug Administration and Medicare and Medicaid. He is also chairman of the Select Committee on Intelligence.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          House panel takes first step toward fixing drug shortages
          House panel takes first step toward fixing drug shortages

          EnergyandCommerceChairCathyMcMorris-Rodgers(R-Wash.)AnnaMoneymaker/GettyImagesWASHINGTON—AHousesubco

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

          ChristineKao/STATTheFoodandDrugAdministration’sapprovalonFridayoftwogenetherapiesforsicklecelldiseas